Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Teladoc Health, Inc.TDOC · Entity 1547 | Director | July 13, 2015 | September 12, 2016 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Teladoc Health, Inc.
Report date July 13, 2015 · Filed September 12, 2016
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 49,986 |
Reported balance
After 2015-07-13 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2015-07-13 · Exercise / conversion · Acquired 897 · Balance 49,986 F1: The number of shares reported in Column 5 is the number of shares beneficially owned as of the date of this filing and takes into account transactions reported by the reporting person on multiple Forms 4 since the date of the transaction reported herein. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.80 · Expires 2018-05-01 | Direct | 0 |
Reported balance
After 2015-07-13 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2015-07-13 · Exercise / conversion · Disposed 897 · Balance 0 |
Filing footnotes · ownership attribution and instrument terms
F1: The number of shares reported in Column 5 is the number of shares beneficially owned as of the date of this filing and takes into account transactions reported by the reporting person on multiple Forms 4 since the date of the transaction reported herein.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 13, 2015 Filed Sep 12, 2016 18:57 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionStock Option (right to buy) · Derivative | 897 | $0.00 Strike: $0.80 | $0.00 |
DisclosureSEC source: 0001179110-16-029547 · edgar.xml · derivative · entry 2 Outland James K · CIK 0001646313 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 897 shares Expires 2018-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 13, 2015 Filed Sep 12, 2016 18:57 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 897 | $0.80 | $717.60 |
DisclosureSEC source: 0001179110-16-029547 · edgar.xml · nonDerivative · entry 1 Outland James K · CIK 0001646313 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,986 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: The number of shares reported in Column 5 is the number of shares beneficially owned as of the date of this filing and takes into account transactions reported by the reporting person on multiple Forms 4 since the date of the transaction reported herein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.